Biomarkers in molecular epidemiology studies for health risk prediction

Mutation Research - Reviews in Mutation Research

Volumn 511, Issue 1, 2002, Pages 73-86

  Bonassi, Stefano ^a   Au, William W ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Biomarkers; Chromosome aberrations; FISH; Gene mutation; Health risk assessment; HPRT; Micronuclei; Molecular epidemiology; Population studies

Indexed keywords

BIOLOGICAL MARKER;

CANCER; CANCER RISK; DATA BASE; DOCUMENTATION; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; GENOME; HEALTH HAZARD; HUMAN; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0036129318     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00003-0     Document Type: Review

References (78)

1. The place of epidemiology in environmental decisions: Needed support for the development of risk assessment policy
2. General issues in the use of biological markers in cancer epidemiology
3. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens
4. Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causation
5. Molecular cancer epidemiology: A new tool in cancer prevention
6. Molecular epidemiology and the genetics of environmental cancer
7. Toward an integrated approach to molecular epidemiology
8. Biological markers in environmental health research
9. ASPO distinguished achievement award lecture. Epidemiological studies using biological markers: Issues for epidemiologists
10. Importance of surrogate markers in evaluation of antiviral therapy for HIV infection
11. Biomarkers and surrogate endpoints in clinical research: Definitions and conceptual model
12. The use of biological markers as predictive early-outcome measures in epidemiological research
13. Workshop report
14. DNA Adducts as markers of exposure to carcinogens and risk of cancer
15. Validation of biomarkers as early predictors of disease
16. Protein adducts of 1,4-benzoquinone and benzene oxide among smokers and nonsmokers exposed to benzene in China
17. Assessing children's exposure to hazardous environmental chemicals: An overview of selected research challenges and complexities
18. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
19. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
20. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
21. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan
22. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
23. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p55
24. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
25. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International programme on chemical safety
26. Mechanisms of chromosomal aberration production. Part III. Chemicals and ionizing radiation
27. Monitoring human population for the effects of radiation and chemical exposures using cytogenetic techniques
28. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
29. Bleomycin and sister-chromatid exchange in human lymphocyte chromosomes
30. Induction of chromosome aberrations and specific locus mutation but not sister chromatid exchanges in Chinese hamster ovary cells by neocarzinostatin
31. Short-term cytogenetic assays of nine cancer chemotherapeutic drugs with metabolic activation
32. Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4
33. Detection of chromosomal breakage in the 1cen-1q12 region of interphase human lymphocytes using multicolor fluorescence in situ hybridization with tandem DNA probes
34. Biological dosimetry of Chernobyl cleanup workers: Inclusion of date on age and smoking provides improved radiation dose estimates
35. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility
36. Biomarkers of leukemia risk: Benzene as a model
37. Carcinogen-specific induction of genetic instability
38. Measurement of micronuclei in human lymphocytes
39. The human micronucleus project - An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans
40. Somatic cell mutations in cancer epidemiology
41. Gene mutations with characteristic deletions in cord blood T-lymphocytes associated with passive maternal exposure to tobacco smoke
42. Biological monitoring for mutagenic effects of occupational exposure to butadiene
43. Correlated mutagenesis of bcl2 and hprt loci in blood lymphocytes
44. New approaches to understanding p53 gene tumor mutation spectra
45. Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131
46. HPRT and gylcophorin A mutations in foundry workers: Relationship to PAH exposure and to PAH-DNA adducts
47. A study of the effects of exposure on cleanup workers at the Chernobyl nuclear reactor accident using multiple end points
48. Human in vivo somatic mutation measured at two loci: Individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies
49. Validation of biological markers for quantitative risk assessment
50. The light at the end of the tunnel for chemical-specific biomarkers: Daylight or headlight?
51. Biomonitoring using accessible human cells for exposure and health risk assessment
52. Detection of onocogene mutations in sputum precedes diagnosis of lung cancer
53. High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer
54. K-ras point mutation detection in lung cancer: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification
55. Somatic screening of individuals harboring K-ras mutations with the use of plasma DNA
56. Shared cytogenetic abnormalities in lung tumours and corresponding peripheral blood lymphocytes
57. Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage
58. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study
59. Chromosomal aberrations in lymphocytes predict human cancer - A report from the European study group on cytogenetic biomarkers and health (ESCH)
60. Chromosomal aberrations in lymphocytes predict human cancer independently from exposure to carcinogens
61. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area
62. Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations
63. Chromosome painting for cytogenetic monitoring of occupationally exposed and non-exposed groups of human individuals
64. Radiation-induced chromosome damage in astronauts' lymphocytes
65. Risk estimation based on chromosomal aberrations induced by radiation
66. A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers
67. Meta-analysis of observational studies in epidemiology
68. Traditional reviews, meta-analyses and pooled analyses in epidemiology
69. The human micronucleus project. International data base comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes. Part I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei
70. Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke/oven workers
71. The relationship between genotype and chromosome aberration frequencies in a normal adult population
72. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers
73. Importance of genetic polymorphisms for enzymes involved in the biotransformation of styrene in humans and interest for interpretation of biomarkers of exposure
74. Metabolic polymorphisms of importance in biomonitoring
75. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity
76. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene
77. Factors contributing to discrepancies in population monitoring studies
78. Molecular epidemiology: On the path to prevention